Dr.pharmacist
Jarro-Dophilus EPS

Jarro-Dophilus EPS

OTC DrugJarro-Dophilus EPS
Reviewed by Younghun Cho

Pharmacist's Verdict

Jarro-Dophilus EPS is a well-formulated, reliable daily probiotic from a reputable brand that is excellent for general gut health support. Its special enteric-coated capsule is a key feature that helps ensure the live bacteria survive stomach acid to do their job.

Ingredient Analysis

Proprietary Probiotic Blend (Lactobacillus, Bifidobacterium, etc.)

EnteroGuard Coating (Sodium alginate, magnesium stearate, etc.)

Potato Starch

Pros & Cons

Pros

  • Contains eight different, well-studied strains of beneficial bacteria to support overall gut health.
  • Features a special coating (EnteroGuard) that protects the live bacteria from stomach acid, helping them reach the intestines alive.
  • Shelf-stable, meaning it does not require refrigeration, which is very convenient for storage and travel.
  • Made by Jarrow Formulas, a brand with a strong reputation for quality and testing in the supplement industry.

Cons

  • More expensive than many basic, single-strain probiotics on the market.
  • May cause temporary gas, bloating, or digestive upset for the first few days of use as your body adjusts.
  • People who are severely immunocompromised or critically ill should talk to a doctor before taking any probiotic supplement.

References

  1. 1.
  2. 2.
    Diagnostic performance of ultrasound in acute cholecystitis: a systematic review and meta-analysis.

    Huang SS, Lin KW, Liu KL, et al., World journal of emergency surgery : WJES, 2023 · PubMed

  3. 3.
    Psychosocial safety climate: a multilevel theory of work stress in the health and community service sector.

    Dollard MF, McTernan W, Epidemiology and psychiatric sciences, 2011 · PubMed

  4. 4.
    A critical overview of emotion processing assessment in non-affective and affective psychoses.

    Gorrino I, Rossetti MG, Girelli F, et al., Epidemiology and psychiatric sciences, 2024 · PubMed

  5. 5.
    Reducing mental health-related stigma in primary health care settings in low- and middle-income countries: a systematic review.

    Heim E, Kohrt BA, Koschorke M, et al., Epidemiology and psychiatric sciences, 2018 · PubMed